TMX Group Price Target Raised By $2 at RBC

FINWIRES Analysis

RBC frames the RAFI Indices deal as accretive and geographically diversifying, reducing TMX's reliance on domestic Canadian listings toward recurring index-licensing revenue. Full debt financing adds leverage risk but the modest accretion and discounted peer multiple support the constructive view. Integration execution and the projected Q4/26 close timing are the items to watch.

Key Takeaways

Index deal diversifies revenue beyond Canada

Debt-funded but modestly accretive per RBC

Trades at discount to global exchange peers

RBC Capital Markets raised its price target on TMX Group Ltd. (X.TO) to $71 from $69 on Monday.

Analyst Bart Dziarski maintained an Outperform rating on shares of the Canadian financial services company.

On June 11, TMX announced that it was acquiring RIFI Indices for US$490 Million.

"We believe TMX's acquisition of RAFI Indices from Research Affiliates represents an accretive deployment of capital (we estimate ~3%) and is strategically sound with recurring revenue, revenue outside Canada, and revenue from Global Insights all increasing," Dziarski said in a note to clients.

"We assume Q4/26 close and increase our 2027 estimates to reflect the transaction (which is entirely debt financed)," the analyst said.

"Valuation remains attractive with TMX trading at 18x 2027E P/E, a 2x discount to global peers and below its 5-year average."

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Goldman Sachs Downgrades Signify to Neutral

Goldman Sachs on Friday downgraded Dutch lighting company Signify (LIGHT.AS) to neutral from buy, while maintaining its price target at 21 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LIGHT.AS

Citi Upgrades Halma to Buy Rating, Boosts PT

Citi on Friday raised life-saving technology group Halma (HLMA.L) to buy from neutral and increased its price target to 46 pounds sterling from 37 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$HLMA.L

Riyad Capital Reduces Al-Dawaa Medical Services' PT, Keeps at Neutral

Riyad Capital on Thursday decreased the price target for Saudi Arabian medical services company and pharmacy operator Al-Dawaa Medical Services (SASE:4163) to 45 Saudi riyals from 50 riyals and kept its neutral rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

SASE:4163